The discovery of a series of selective EP1 receptor antagonists based on a 1,2-diarylcyclopentene template is described. After defining the structural requirements for EP1 potency and selectivity, heterocyclic rings were incorporated to reduce logD and improve in vitro pharmacokinetic properties. The 2,6-substituted pyridines and pyridazines gave an appropriate balance of potency, in vivo pharmacokinetic properties and a low potential for inhibiting a range of CYP450 enzymes. From this series, GW848687X was shown to have an excellent profile in models of inflammatory pain and was selected as a development candidate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.10.041DOI Listing

Publication Analysis

Top Keywords

ep1 receptor
8
inflammatory pain
8
pharmacokinetic properties
8
discovery 6-[2-5-chloro-2-{[24-difluorophenylmethyl]oxy}phenyl-1-cyclopenten-1-yl]-2-pyridinecarboxylic
4
6-[2-5-chloro-2-{[24-difluorophenylmethyl]oxy}phenyl-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid
4
acid gw848687x
4
gw848687x potent
4
potent selective
4
selective prostaglandin
4
prostaglandin ep1
4

Similar Publications

The urothelium and lamina propria (LP) contribute to sensations of bladder fullness by releasing multiple mediators, including prostaglandins (PGs) and adenosine 5'-triphosphate (ATP), that activate or modulate functions of cells throughout the bladder wall. Mediators that are simultaneously released in response to bladder distention likely influence each other's mechanisms of release and action. This study investigated whether PGs could alter the extracellular hydrolysis of ATP by soluble nucleotidases (s-NTDs) released in the LP of nondistended or distended bladders.

View Article and Find Full Text PDF

The haemocyte highly-expressed E-type prostanoid receptor regulates TNF expression during immune response of oyster Crassostrea gigas.

Fish Shellfish Immunol

December 2024

Liaoning Key Laboratory of Marine Animal Immunology and Disease Control, Dalian Ocean University, Dalian, 116023, China; Laboratory of Marine Fisheries Science and Food Production Process, Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266235, China; Liaoning Key Laboratory of Marine Animal Immunology, Dalian Ocean University, Dalian, 116023, China; Dalian Key Laboratory of Aquatic Animal Disease Prevention and Control, Dalian Ocean University, Dalian, 116023, China.

Prostaglandin E2 imparts diverse physiological effects on multiple cells through its actions on four distinct E-type prostanoid (EP) receptor subtypes (EP1-EP4), among which the EP4 is one of subtypes known to mediate the immune response in mammalian monocytes and macrophages. However, the precise characteristics and functions of EP4 in mollusks remain unclear. In the present study, an EP4 homologue (designated as CgEP4) was identified from oyster Crassostrea gigas.

View Article and Find Full Text PDF

EP4: A prostanoid receptor that modulates insulin signalling in rat skeletal muscle cells.

Cell Signal

February 2025

Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Electronic address:

The EP4 (prostaglandin E2) receptor plays a crucial role in myogenesis and skeletal muscle regeneration, yet its involvement in regulating insulin-dependent metabolic pathways is not well characterised. Our research investigates the expression of EP4 in rat skeletal L6 myotubes and its impact on insulin signalling. We found that activation of EP4 by selective agonists disrupts insulin signalling and insulin-stimulated glucose uptake.

View Article and Find Full Text PDF
Article Synopsis
  • Gastric carcinomas (GCs) are aggressive cancers, with only 15% of patients responding to anti-PD-(L)1 treatments, but those associated with Epstein-Barr virus (EBV) exhibit better responses and unique immune characteristics.
  • A study analyzed tumor immune microenvironments in 25 treatment-naïve GCs, comparing 11 EBV+ and 14 EBV- cases using immunohistochemistry and gene expression profiling.
  • Results showed EBV+ GCs had higher densities of CD8+ T cells and distinct immune gene expression patterns, while EBV- GCs demonstrated increased inflammatory and immunosuppressive gene signatures, suggesting differing mechanisms of immune evasion.
View Article and Find Full Text PDF

The observed increase in the production of enzyme preparations (EP) using mutant and genetically modified microorganisms makes it necessary to assess their risks to consumer health. However, at present, their possible influence on the microbiome, immune status of the macroorganism has not been sufficiently studied. of the research was to assess the effect of two EP - the complex of hydrolases with proteolytic and nuclease activity from the Aspergillus oryzae RCAM 01134 mutant strain (EP1) and the neutral protease - bacillolysin and serine protease from the Bacillus subtilis-96 (VKM B-3499D) mutant strain (FP2) on the intestine microbiome and cellular immunity indices of the experimental animals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!